{
    "title": "GSK bets $2 bln on Bellus cough drug to soothe pipeline fears",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11984437/GSK-buy-Canadas-Bellus-Health-2-bln.html",
    "date": "2023-04-18",
    "keywords": [
        "drug",
        "deal",
        "camlipixant",
        "year",
        "respiratory",
        "loss",
        "grover",
        "aby",
        "bellus",
        "drugmaker",
        "pipeline",
        "decade",
        "patent",
        "protection",
        "portfolio",
        "gefapixant",
        "part",
        "company",
        "vaccine",
        "gap",
        "developer",
        "health",
        "inc",
        "bet",
        "move",
        "medicine",
        "cabinet",
        "momentum",
        "heart",
        "tuesday",
        "latestage",
        "development",
        "refractory",
        "cough",
        "condition",
        "day",
        "europe",
        "offer",
        "share",
        "closing",
        "price",
        "nasdaq",
        "trelegy",
        "rcc",
        "approval",
        "regulator",
        "information",
        "effectiveness",
        "application",
        "review",
        "option",
        "safety",
        "profile",
        "note",
        "month",
        "compound",
        "hiv",
        "risk",
        "virus",
        "rsv",
        "string",
        "buyout",
        "affinivax",
        "sierra",
        "oncology",
        "handful",
        "cancer",
        "demand",
        "flagship",
        "blockbuster",
        "shingrix",
        "impact",
        "half",
        "officer",
        "briefing",
        "jose",
        "koilparambil",
        "bengaluru",
        "editing",
        "dsouza",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}